43
3
2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9967 | MAGL-IN-5 | Lipid | |
MAGL-IN-5 is a non-selective lipase inhibitor. | |||
T9687 | MAGL-IN-4 | His121 ARG57 | Lipase |
MAGL-IN-4 (His121 ARG57) is one of the monoacylglycerol lipase (MAGL) inhibitors in central nervous system-related diseases. | |||
T11939 | MAGL-IN-1 | Lipase | |
MAGL-IN-1 is a selective and potent monoacylglycerol lipase (MAGL) inhibitor with an IC50 of 80 nM. | |||
T81879 | MAGL-IN-8 | MAGL | |
MAGL-IN-8 (compound 13) serves as a reversible inhibitor of monoacylglycerol lipase (MAGL), exhibiting an inhibitory concentration half-maximal (IC50) value of 2.5 ± 0.4 nM for human MAGL (hMAGL) [1]. | |||
T81880 | MAGL-IN-11 | MAGL | |
MAGL-IN-11 (compound 29) is a selective, reversible inhibitor of monoacylglycerol lipase (MAGL), with potential in researching inflammation, cancer, and antioxidants [1]. | |||
T61707 | FAAH/MAGL-IN-2 | ||
FAAH/MAGL-IN-2, a potent and reversible inhibitor of FAAH and MAGL, demonstrates oral activity and the ability to cross the blood-brain barrier. It exhibits IC50 values of 11 nM for FAAH and 36 nM for MAGL (Ki values of ... | |||
T62489 | MAGL-IN-6 | ||
MAGL-IN-6 is a potent inhibitor of MAGL (IC50: 4.71 nM). MAGL-IN-6 can be used to study neurological diseases. | |||
T81878 | MAGL-IN-9 | MAGL | |
MAGL-IN-9, also referred to as compound 16, is a reversible inhibitor of monoacylglycerol lipase (MAGL) with a potent IC50 value of 2.7 nM [1]. | |||
T81881 | MAGL-IN-10 | MAGL | |
MAGL-IN-10, a reversible monoacylglycerol lipase (MAGL) inhibitor, exhibits favorable ADME properties and low in vivo toxicity. It is applicable in the study of cancer, neurological disorders, and inflammatory pathologie... | |||
T62671 | FAAH/MAGL-IN-3 | ||
FAAH/MAGL-IN-3 (Compound 10) is an irreversible dual inhibitor of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) that acts on FAAH (IC50: 179 nM) and MAGL (IC50: 759 nM). FAAH/MAGL-IN-3 showed littl... | |||
T61198 | FAAH/MAGL-IN-1 | ||
FAAH/MAGL-IN-1, also known as compound SIH 3, is a highly effective inhibitor of FAAH (fatty acid amide hydrolase) and MAGL (monoacylglycerol lipase). It exhibits IC50 values of 31 nM and 29 nM against FAAH and MAGL, res... | |||
T15614 | JJKK 048 | Lipase | |
JJKK 048 is a potent and selective MAGL inhibitor. | |||
T15635 | JZP-430 | Lipase , MAGL | |
JZP-430 is an effective, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) (IC50: 44 nM). It also shows ~230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL... | |||
T8974 | ML-211 | Others | |
ML-211 is a carbamate-based dual inhibitor of LYPLA1 (IC50 = 17 nM) and the related LYPLA2 (IC50 = 30 nM) | |||
T5353 | ABX-1431 | Elcubragistat | Lipase |
ABX-1431 (Elcubragistat) is a selective and orally available CNS-penetrant monoacylglycerol lipase (MAGL/MGLL) inhibitor (IC50: 14 nM). | |||
T15632 | JW 642 | Lipase | |
JW 642 is an effective inhibitor of monoacylglycerol lipase (MAGL) (IC50: 7.6, 14, and 3.7 nM for inhibition of MAGL in mouse, rat, and human brain membranes, respectively). | |||
T17260 | WWL70 | Lipase , MAGL | |
WWL70 is a selective alpha/beta hydrolase domain 6 inhibitors (IC50: 70 nM). | |||
T4052 | KML29 | Lipase | |
KML29 is highly selective and effective monoacylglycerol lipase (MAGL) inhibitor. It has effective inhibition of human/mouse/rat MAGL (IC50: 5.9/15/43 nM). It has not inhibitory for FAAH (IC50 > 50 μM). It also effective... | |||
T6554 | JZL 184 | JZL184 | Lipase |
JZL 184 is a potent and selective inhibitor of MAGL with IC50 of 8 nM and 4 μM for inhibition of MAGL and FAAH in mouse brain membranes respectively. | |||
T5815 | MJN110 | Cravatt Reagent | Lipase |
MJN110 (Cravatt Reagent) is a potent and selective MAGL inhibitor. Cravatt Reagent inhibits MAGL (IC50 = 9.1 nM). MJN110(Cravatt Reagent) Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model. | |||
T2338 | JZL195 | FAAH , Lipase , Autophagy | |
JZL195 is a selective and efficacious dual FAAH/MAGL inhibitor. | |||
T8994 | ML-226 | ML226,ML-226 | MAGL |
ML226 is a α/β hydrolase domain-containing protein 11 (ABHD11) inhibitor that inhibits ABHD11 in vitro and in situ. | |||
T9374 | AA38-3 | 1-Piperidinecarboxylic acid, 4-nitrophenyl ester | FAAH , Lipase , MAGL |
AA38-3 (1-Piperidinecarboxylic acid, 4-nitrophenyl ester) inhibites three SHs (ABHD6, ABHD11, and FAAH) | |||
T61972 | Pomaglumetad methionil hydrochloride | LY2140023 hydrochloride | GluR |
Pomaglumetad methionine hydrochloride (LY2140023 hydrochloride) is a methionine prodrug of LY404039 with oral activity. LY404039 is a selective mGlu2/3 receptor agonist. Pomaglumetad methionil hydrochloride (LY2140023 hy... | |||
T19850 | Semaglutide | Glucagon Receptor | |
Semaglutide is a glucagon-like peptide 1 receptor (GLP-1R) agonist(EC50 of 6.2 pM in a reporter assay using BHK cells expressing the human receptor). | |||
T19850L | Semaglutide Acetate | Semaglutide Acetate(910463-68-2 Free base) | Glucagon Receptor |
Semaglutide Acetate is an agonist of a glucagon-like peptide 1 (GLP-1) receptor and can be used in studies about the treatment of type 2 diabetes. | |||
T62937 | MAGLi 432 | ||
MAGLi 432 is a potent, highly selective, non-covalent, reversible (MAGL) inhibitor that binds with high affinity to the MAGL active site, with IC50 values of 4.2 nM (human enzyme) and 3.1 nM (mouse enzyme), MAGLi 432 can... | |||
T80879 | Vamagloxistat | ||
Vamagloxistat is a glycolate oxidase inhibitor utilized to mitigate hyperoxaluria and reduce the formation of kidney stones [1]. | |||
T11907 | Pomaglumetad methionil anhydrous | LY2140023 | GluR |
LY2140023 has the potential for schizophrenia.LY2140023 is an orally active prodrug of LY404039. LY404039 is a selective metabotropic glutamate 2/3 receptor agonist. | |||
T12520 | Pomaglumetad methionil | LY2140023 hydrate | GluR |
Pomaglumetad methionil is an oral methionine prodrug of the potent specific agonist of mGlu2/3 receptor LY404039. | |||
T12878 | Semaglutide TFA (910463-68-2 free base) | Semaglutide TFA | Glucagon Receptor |
Semaglutide TFA is a agonist of glucagon-like peptide-1 (GLP-1) receptor,with a potential for type 2 diabetes treatment. | |||
T69191 | Pemaglitazar | ||
Pemaglitazar is a dual peroxisome proliferator-activated receptor (PPAR) alpha and gamma agonist, with hypoglycemic activity. | |||
T27703 | JZP-361 | JZP361,JZP 361 | Lipase |
JZP-361 is a specific MAGL inhibitor with IC50s of 46 nM, 7.24 μM, and 1.79 μM for human recombinant MAGL, human recombinant FAAH, and human hABHD6. JZP-361 displays anti-histaminergic activities. JZP-361 can be used in ... | |||
T11724 | JNJ-42226314 | Lipase | |
JNJ-42226314 is a highly selective non-covalent monoacylglycerol lipase (MAGL) inhibitor with anti-injury effects.JNJ-42226314 shows efficacy via endogenous cannabinoid-2-acryloylglycerol (2-AG) in models of neuropathic ... | |||
T16496 | PF-06795071 | Lipase | |
PF-06795071 is an effective and selective covalent inhibitor of MAGL (IC50: 3 nM). | |||
T24758 | SAR127303 | SAR-127303,SAR 127303 | |
SAR127303 is an effective covalent inhibitor of MAGL. SAR127303 behaves as a selective and competitive inhibitor of mouse and human MAGL. | |||
T37374 | URB754 | ||
URB754 is a potent and noncompetitive inhibitor of monoacylglycerol lipase (MAGL), exhibiting an IC50 value of 200 nM for the recombinant rat brain enzyme. However, it does not inhibit human recombinant, rat brain, or mo... | |||
T28235 | OMDM169 | OMDM 169,OMDM-169 | |
OMDM169 is a potent and selective MAGL inhibitor. OMDM169 could enhances 2-AG levels and of exerts analgesic activity via indirect activation of cannabinoid receptors. OMDM169 exhibited 0.13 microM<IC(50)<0.41 microM tow... | |||
T21905 | N-Arachidonyl Maleimide | ||
N-Arachidonyl maleimide is a potent, irreversible monoacylglycerol lipase (MAGL) inhibitor with an IC 50 value of 140 nM [1]. | |||
T36498 | CAY10762 | CAY10762 | |
CAY10762 is an inhibitor of monoacylglycerol lipase (MAGL; IC50= 34.1 nM).1It reduces hydrogen peroxide-induced lactate dehydrogenase (LDH) release from Neuro2a cells when used at a concentration of 1 μM. CAY10762 (10 mg... | |||
T37629 | IDFP | ||
The endocannabinoids, 2-arachidonoyl glycerol (2-AG) and arachidonoyl ethanolamide (AEA), are biologically active lipids that regulate diverse neurological and metabolic functions by activating the cannabinoid receptors,... | |||
T73317 | JZP-MA-13 | ||
JZP-MA-13 is a selective α/β-hydrolase domain 6 (ABHD6) inhibitor, demonstrating impressive specificity with an IC50 value of 392 nM, and exhibits no inhibitory effects on monoacylglycerol lipase (MAGL), ABHD12, fatty ac... | |||
T12826 | SA57 | FAAH | |
SA57 is a potent, selective inhibitor of FAAH(IC50s of 3.2 nM and 1.9 nM for mouse and human FAAH). |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T5737 | Euphol | Others , Lipase , Endogenous Metabolite | |
Euphol, an alcohol tetracyclic triterpene, has a wide range of pharmacological properties and is considered to have anti-inflammatory action. | |||
TN5409 | Maglifloenone | Denudatone | |
Maglifloenone is a natural product of Magnolia, Magnoliaceae. The catalog number is TN5409 and the CAS number is 82427-77-8. Maglifloenone can be used as a reference standard. | |||
TN4904 | Rehmaglutin D | Others | |
Rehmaglutin D is a natural product of Ailanthus, Simaroubaceae. The catalog number is TN4904 and the CAS number is 103744-84-9. Rehmaglutin D can be used as a reference standard. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00025 | Mammaglobin B/SCGB2A1 Protein, Human, Recombinant (hFc) | Human | HEK293 |
SCGB2A1 represented a novel, prognostic factor for CRC, and that expression of SCGB2A1 correlated with chemoresistance, radioresistance and cancer cell stemness. SCGB2A1 is a top differentially expressed gene in all majo... | |||
TMPH-01637 | Mammaglobin-A/SCGB2A2 Protein, Human, Recombinant (GST) | Human | E. coli |
Mammaglobin-A/SCGB2A2 Protein, Human, Recombinant (GST) is expressed in E. coli. |